Astellas Pharma, Inc. (ALPMY)
14.32
-0.12
(-0.83%)
USD |
OTCM |
Oct 02, 16:00
Astellas Pharma Max Drawdown (5Y) : 51.90% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 51.90% |
| August 31, 2026 | 51.90% |
| July 31, 2026 | 51.90% |
| June 30, 2026 | 51.90% |
| May 31, 2026 | 51.90% |
| April 30, 2026 | 51.90% |
| March 31, 2026 | 51.90% |
| February 28, 2026 | 51.90% |
| January 31, 2026 | 51.90% |
| December 31, 2025 | 51.90% |
| November 30, 2025 | 51.90% |
| October 31, 2025 | 51.90% |
| September 30, 2025 | 51.90% |
| August 31, 2025 | 51.90% |
| July 31, 2025 | 51.90% |
| June 30, 2025 | 51.90% |
| May 31, 2025 | 51.90% |
| April 30, 2025 | 51.90% |
| March 31, 2025 | 50.33% |
| February 28, 2025 | 50.33% |
| January 31, 2025 | 49.67% |
| December 31, 2024 | 49.67% |
| November 30, 2024 | 49.67% |
| October 31, 2024 | 49.67% |
| September 30, 2024 | 49.67% |
| Date | Value |
|---|---|
| August 31, 2024 | 49.67% |
| July 31, 2024 | 49.67% |
| June 30, 2024 | 49.67% |
| May 31, 2024 | 49.67% |
| April 30, 2024 | 49.67% |
| March 31, 2024 | 42.35% |
| February 29, 2024 | 41.75% |
| January 31, 2024 | 38.33% |
| December 31, 2023 | 38.33% |
| November 30, 2023 | 37.19% |
| October 31, 2023 | 32.38% |
| September 30, 2023 | 29.44% |
| August 31, 2023 | 29.44% |
| July 31, 2023 | 29.44% |
| June 30, 2023 | 29.44% |
| May 31, 2023 | 29.44% |
| April 30, 2023 | 29.44% |
| March 31, 2023 | 29.44% |
| February 28, 2023 | 29.44% |
| January 31, 2023 | 29.44% |
| December 31, 2022 | 29.44% |
| November 30, 2022 | 29.44% |
| October 31, 2022 | 29.44% |
| September 30, 2022 | 29.44% |
| August 31, 2022 | 29.44% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 50.60% |
| Daiichi Sankyo Co., Ltd. | 64.07% |
| Ono Pharmaceutical Co., Ltd. | 69.70% |
| Eisai Co., Ltd. | 95.02% |
| Chugai Pharmaceutical Co., Ltd. | 59.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -7.414 |
| Beta (5Y) | 0.1013 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 25.14% |
| Historical Sharpe Ratio (5Y) | -0.2546 |
| Historical Sortino (5Y) | -0.5057 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.56% |